V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010241 | 280005581 | 1.82 | 90 | Palliative (P) | 2014-08-27 | 2014-09-01 | Cisplatin | 02 | N | 280027410 | CISPLATIN |
| 280010242 | 280005582 | 1.82 | 56.1 | Adjuvant (A) | 2015-01-22 | 2014-11-27 | CARBOPLATIN + RT | 02 | Y | 280027415 | CARBOPLATIN + RT |
| 280010243 | 280005584 | 1.75 | 78 | Palliative (P) | 2016-03-06 | 2016-03-06 | Cyclophosphamide oral | null | null | 280027424 | CYCLOPHOSPHAMIDE |
| 280010244 | 280005585 | 1.6 | null | Palliative (P) | 2015-12-02 | 2016-02-01 | Carboplatin + Etoposide IV 3 day | null | null | 280027425 | CARBOPLATIN + ETOPOSIDE |
| 280010245 | 280005587 | 1.57 | 71.6 | Palliative (P) | 2014-07-25 | 2014-08-24 | CISPLATIN + FLUOROURACIL | 02 | N | 280027434 | CISPLATIN + FLUOROURACIL |
| 280010246 | 280005590 | 1.73 | 59.2 | Adjuvant (A) | 2018-12-20 | 2019-01-29 | Doxorubicin + Ifosfamide | null | null | 280027445 | DOXORUBICIN + IFOSFAMIDE |
| 280010247 | 280005590 | null | 104 | Not known (9) | 2015-07-11 | 2015-09-29 | CISPLATIN + FLUOROURACIL | N | N | 280027445 | CISPLATIN + FLUOROURACIL |
| 280010248 | 280005593 | 1.72 | 60.1 | null | 2013-11-23 | 2014-01-08 | Cetuximab+Cisplatin+FU (> Cycle 2) | 2 | N | 280027461 | CETUXIMAB + CISPLATIN + FU |
| 280010249 | 280005596 | 1.84 | 59.7 | Curative (C) | 2018-03-26 | 2018-04-24 | CISPLATIN + FLUOROURACIL | N | Y | 280027474 | CISPLATIN + FLUOROURACIL |
| 280010250 | 280005599 | 1.68 | 81 | Curative (C) | 2017-11-30 | 2017-12-12 | CARBOPLATIN + PACLITAXEL | 02 | N | 280027482 | CARBOPLATIN + PACLITAXEL |
| 280010251 | 280005601 | 1.73 | 117.4 | Palliative (P) | 2016-11-22 | 2016-12-09 | Carboplatin + Etoposide iv&po | N | N | 280027501 | CARBOPLATIN + ETOPOSIDE |
| 280010252 | 280005603 | 1.66 | null | Palliative (P) | 2018-12-05 | 2018-12-13 | DE-ESCALATE TRIAL | null | null | 280027523 | DE-ESCALATE TRIAL |
| 280010253 | 280005605 | 1.61 | 65 | Palliative (P) | 2013-07-19 | 2013-07-26 | Cetuximab+Cisplatin+FU (> Cycle 2) | 01 | N | 280027524 | CETUXIMAB + CISPLATIN + FU |
| 280010254 | 280005606 | 1.84 | null | Curative (C) | 2016-10-04 | 2016-12-06 | Irinotecan + Modified De Gramont | 02 | Y | 280027530 | IRINOTECAN + MDG |
| 280010255 | 280010554 | 1.72 | 94 | Curative (C) | null | 2015-10-09 | Cetuximab +Cisplatin + FU (Cycle 1) | N | Y | 280027534 | CETUXIMAB + CISPLATIN + FU |
| 280010256 | 280005611 | 1.86 | 70.9 | Palliative (P) | 2016-08-22 | 2016-09-19 | Etoposide + Ifosfamide (3 days) | 1 | N | 280027539 | ETOPOSIDE + IFOSFAMIDE |
| 280010257 | 280005613 | 1.66 | 96 | Palliative (P) | 2015-12-13 | 2015-12-18 | Carboplatin + Paclitaxel (weekly) | 02 | N | 280027543 | CARBOPLATIN + PACLITAXEL |
| 280010258 | 280005617 | 1.84 | 83.7 | Palliative (P) | null | 2015-10-24 | ETOPOSIDE + IFOSFAMIDE | N | N | 280027545 | ETOPOSIDE + IFOSFAMIDE |
| 280010259 | 280005621 | 1.61 | 74.4 | Curative (C) | 2015-10-13 | 2016-03-26 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 280027549 | CISPLATIN + GEMCITABINE |
| 280010260 | 280005624 | 1.74 | 56.4 | Adjuvant (A) | null | 2014-02-24 | Carboplatin + Etoposide IV 3 day | null | null | 280027560 | CARBOPLATIN + ETOPOSIDE |
| 280010261 | 280005624 | null | 71 | Neo-adjuvant (N) | 2017-12-29 | 2017-12-29 | Doxorubicin + Ifosfamide | 02 | N | 280027560 | DOXORUBICIN + IFOSFAMIDE |
| 280010262 | 280005624 | 1 | 82.4 | Neo-adjuvant (N) | 2016-04-26 | 2016-05-05 | Oxaliplatin + Modified de Gramont | 02 | N | 280027560 | OXALIPLATIN + MDG |
| 280010263 | 280005625 | 1.79 | 76.4 | Palliative (P) | 2016-11-01 | 2016-11-02 | Cisplatin +Fluorouracil (3 wk) | 01 | N | 280027573 | CISPLATIN + FLUOROURACIL |
| 280010264 | 280005629 | 1.63 | 89.9 | null | 2014-11-11 | 2015-01-06 | Carboplatin + Etoposide IV 3 day | N | N | 280027586 | CARBOPLATIN + ETOPOSIDE |
| 280010265 | 280005631 | 1.77 | 64.3 | Curative (C) | 2015-06-22 | 2015-06-22 | FLUOROURACIL + OXALIPLATIN | N | N | 280027591 | OXALIPLATIN + MDG |
| 280010266 | 280005632 | 1.5 | 36.1 | Curative (C) | 2014-07-31 | 2014-12-16 | ETOPOSIDE + IFOSFAMIDE | N | N | 280027595 | ETOPOSIDE + IFOSFAMIDE |
| 280010267 | 280010560 | 1.71 | 69.7 | Palliative (P) | 2017-01-29 | 2017-09-18 | Gemcitabine day 1&8 | N | N | 280027599 | GEMCITABINE |
| 280010268 | 280005634 | 1.72 | 70.4 | Curative (C) | 2018-05-08 | 2018-10-18 | CISPLATIN + GEMCITABINE | 02 | N | 280027606 | CISPLATIN + GEMCITABINE |
| 280010269 | 280005636 | 1.78 | 56.4 | Palliative (P) | 2018-02-13 | 2018-02-13 | Etoposide + Ifosfamide (3 days) | N | N | 280027609 | ETOPOSIDE + IFOSFAMIDE |
| 280010270 | 280005639 | 1.78 | 60.4 | Palliative (P) | 2016-05-23 | 2016-10-05 | Cyclophosphamide oral | N | N | 280027612 | CYCLOPHOSPHAMIDE |
| 280010271 | 280011916 | 1.57 | 50.8 | Curative (C) | 2016-08-06 | 2017-12-10 | CISPLATIN + FLUOROURACIL | 02 | N | 280027613 | CISPLATIN + FLUOROURACIL |
| 280010272 | 280005641 | 1.68 | null | Adjuvant (A) | 2016-09-27 | 2016-09-27 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | N | 280027614 | CETUXIMAB + CISPLATIN + FU |
| 280010273 | 280005643 | 1.74 | 46 | Palliative (P) | 2016-08-22 | 2016-08-22 | Irinotecan + Temozolomide | N | N | 280027616 | IRINOTECAN + MDG |
| 280010274 | 280005645 | 1.8 | null | null | 2016-06-15 | 2016-07-10 | Gemcitabine day 1&8 | N | N | 280027619 | GEMCITABINE |
| 280010275 | 280010563 | 165 | 51 | Curative (C) | 2018-03-07 | 2018-03-07 | Cyclophosphamide oral | 02 | null | 280027630 | CYCLOPHOSPHAMIDE |
| 280010276 | 280005648 | 1.8 | 57 | Palliative (P) | 2017-11-18 | 2017-11-19 | Doxorubicin + Olaratumab | N | N | 280027631 | DOXORUBICIN + OLARATUMAB |
| 280010277 | 280005650 | 1.75 | 46.8 | null | 2017-10-09 | 2018-05-02 | CISPLATIN + FLUOROURACIL | N | N | 280027641 | CISPLATIN + FLUOROURACIL |
| 280010278 | 280005652 | 1.71 | 75.4 | Neo-adjuvant (N) | 2017-12-02 | 2017-12-02 | CYCLOPHOSPHAMIDE | N | N | 280027643 | CYCLOPHOSPHAMIDE |
| 280010279 | 280005654 | 1.69 | 105 | Palliative (P) | 2016-06-02 | 2016-06-02 | Gemcitabine day 1&8 | N | N | 280027649 | GEMCITABINE |
| 280010280 | 280008965 | 1.73 | 77.1 | Neo-adjuvant (N) | 2015-07-26 | 2015-08-23 | Gemcitabine day 1&8 | N | N | 280027657 | GEMCITABINE |
| 280010281 | 280011724 | 1.73 | 74.1 | Palliative (P) | 2018-03-26 | 2018-03-26 | Etoposide + Ifosfamide (3 days) | Y | N | 280027660 | ETOPOSIDE + IFOSFAMIDE |
| 280010282 | 280005656 | 1.65 | 79 | Palliative (P) | 2018-03-27 | 2018-04-05 | Doxorubicin + Ifosfamide | null | null | 280027663 | DOXORUBICIN + IFOSFAMIDE |
| 280010283 | 280005658 | 1.8 | 64.8 | Palliative (P) | 2016-06-03 | 2016-06-03 | CARBOPLATIN + PACLITAXEL | N | N | 280027668 | CARBOPLATIN + PACLITAXEL |
| 280010284 | 280008969 | 1.77 | 71 | Curative (C) | null | 2014-02-27 | Carboplatin + Etoposide iv&po | 2 | N | 280027678 | CARBOPLATIN + ETOPOSIDE |
| 280010285 | 280005661 | 1.8 | 43 | Palliative (P) | 2018-08-25 | 2018-11-10 | Cetuximab +Cisplatin + FU (Cycle 1) | null | null | 280027682 | CETUXIMAB + CISPLATIN + FU |
| 280010286 | 280005663 | 1.65 | 54.2 | Palliative (P) | 2015-10-06 | 2015-10-06 | DE-ESCALATE TRIAL | 2 | N | 280027684 | DE-ESCALATE TRIAL |
| 280010287 | 280005665 | null | 70.6 | Palliative (P) | 2019-01-02 | 2019-01-27 | CISPLATIN + GEMCITABINE | N | N | 280027692 | CISPLATIN + GEMCITABINE |
| 280010288 | 280005666 | 1.7 | 64.7 | Neo-adjuvant (N) | 2014-10-27 | 2014-11-17 | VAI (Ifos 3g/m2) | N | N | 280027706 | IRINOTECAN + TEMOZOLOMIDE |
| 280010289 | 280005668 | null | 68 | Adjuvant (A) | 2018-02-05 | 2018-07-02 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 280027711 | CARBOPLATIN + PACLITAXEL |
| 280010290 | 280008975 | 1.76 | 81 | Palliative (P) | 2018-05-30 | 2018-06-24 | Carboplatin + Paclitaxel (3 weekly) | null | null | 280027728 | CARBOPLATIN + PACLITAXEL |